News

Member Portal

About 6% of U.S. Adults Have ADHD, Drug Shortages Are Affecting Treatment

October 10, 2024

FDA is Alerting Patients and Health Care Professionals About the Voluntary Withdrawal of Oxbryta from the Market Due to Safety Concerns

September 26, 2024

Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone OralSuspension Due to Bacterial Contamination

September 17, 2024

Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager

By submitting this form, you are consenting to receive marketing emails from: Benecard Services, LLC. (Lawrenceville, NJ 08648), https://www.benecard.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact.

News

About 6% of U.S. Adults Have ADHD, Drug Shortages Are Affecting Treatment

OTULFI™

FLYRCADO

FDA is Alerting Patients and Health Care Professionals About the Voluntary Withdrawal of Oxbryta from the Market Due to Safety Concerns

COBENFY

AQNEURSA

MIPLYFFA™

Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone OralSuspension Due to Bacterial Contamination

OCREVUS ZUNOVO

Benefit Advisors & Employees - Want to know more?

Benecard

Newsletter